The National Horsemen's Benevolent and Protective Association Medication Committee voted Feb. 23 to endorse the use of race-day furosemide, also called Salix or Lasix, at this year's Breeders' Cup World Championships.
The Breeders' Cup Board discussed the scheduled prohibition of race-day furosemide at this year's Breeders' Cup World Championships during a Feb. 22 meeting at Gulfstream Park, but took no action.
Horsemen expect members of Congress to make another attempt at winning support for legislation that would regulate medication use in racehorses by banning all race-day administration.
The Maryland Racing Commission voted Feb. 19 to adopt a uniform equine medication, penalty, and testing program proposed for Thoroughbred and Standardbred racetracks throughout the Mid-Atlantic region.
Members passed a resolution supporting The Jockey Club's Reformed Racing Medication Rules including a two-category medication system, progressive points-style penalties, and reciprocity among jurisdictions.
A group of scientists met with representatives of the Thoroughbred Owners of California Jan. 18 to discuss exercise-induced pulmonary hemorrhaging and later issued a joint statement supporting use of furosemide.
Legislation calling for a ban on performance-enhancing drugs in horse racing has been sent to the New York Senate Racing, Gaming, and Wagering Committee.
Mary Simon won her second Eclipse Award for an article examining the history and current state of the race-day use of furosemide (Salix).
Members of the Kentucky Horse Racing Commission staff outlined changes that have been put in place to prevent future mistakes in the administration of race-day Salix at the state's tracks.
Kentucky horsemen are losing patience with a new policy that requires regulatory veterinarians to administer furosemide on race day after mistakes have led to horses being scratched on consectutive race days at Churchill.
Trainers Todd Pletcher and Mark Casse took issue with the Breeders' Cup decision banning the anti-bleeding medication furosemide in this year's five juvenile races during the World Thoroughbred Championships.
At its annual conference, IFHA chairman Louis Romanet has applauded the continued efforts of The Jockey Club to prohibit race-day medication in U.S. racing.
A Kentucky state veterinarian accidentally administered furosemide to a racehorse at Keeneland Oct. 5, the first day a new state rule was enacted that requires the medication to be administered by KHRC vets.
Stewards at Turfway Park have slapped trainer Bret Calhoun with a 30-day suspension after a horse in his care tested positive for the prohibited anti-hypertension drug Guanabenz following a win at Churchill Downs May 26.
The West Virginia Racing Commission heard the pros and cons of race-day furosemide use Sept. 17 and pledged to examine the steps necessary to implement mandatory administration of the anti-bleeding drug by third-party vets.
Salix, British Champions Day offer obstacles for Breeders' Cup. read blog
The Kentucky HBPA's statement wasn't the one it hoped to make. read blog
The Kentucky HBPA said Aug. 31 it is "frustrated and extremely disappointed" with the decision by Kentucky Gov. Steve Beshear to override a vote by a legislative committee that found new equine medical rules deficient.
Kentucky Gov. Steve Beshear Aug. 30 said regulations designed to reform some aspects of the state's equine medication policy will be implemented despite action by a legislative committee that found them deficient.
Two national organizations said Aug. 28 they find it "troubling" factions in Kentucky horse racing are opposing medication regulations proposed by the Kentucky Horse Racing Commission but shot down by a legislative committee.
The California Horse Racing Board's Medication and Track Safety Committee has endorsed proposed changes in race-day administration of furosemide.
The West Virginia Racing Commission has officially scheduled a meeting for Sept. 17 to take comments from industry representatives on the use of furosemide, also known as Salix or Lasix, on race day.
A Kentucky legislative subcommittee, in a surprise vote, found regulations governing equine medication "deficient" Aug. 27, just one week before they are scheduled to take effect.
Furosemide will be the only medication permitted on race day in Kentucky effective Sept. 4, and the drug will be administered by regulatory veterinarians only under new Kentucky Horse Racing Commission rules.
In a change designed to win support of its Reformed Racing Medication Rules, The Jockey Club has added a provision governing regulatory administration of furosemide on race day.
There may be plenty of data out there on trainer performance, but for owners, selecting a conditioner involves much more than numbers, according to an owner and trainer that have worked together for about 15 years.
The West Virginia Racing Commission in late summer or early fall plans to hold a fact-finding meeting on use of furosemide on race day, officials said Aug. 4.
- By Tom LaMarra
The majority of National Horsemen's Benevolent and Protective Association affiliates have adopted resolutions calling for continued regulated use of furosemide on race day.
Adding weight to horses racing on Salix would eliminate 'advantage' read blog
While many of racing's major issues were discussed at the July 25 meeting of the board of directors of the Association of Racing Commissioners International, the agenda called for few decisions to be made.
Some of racing's most notable owners pledged to race 2-year-olds of 2012 without furosemide and adjunct bleeder medications, TOBA announced July 19.
Hollywood Casino at Penn National Race Course is the first of three Pennsylvania Thoroughbred tracks to require administration of race-day furosemide by third-party veterinarians.
The Association of Racing Commissioners International is reassessing its policy supporting race-day administration of furosemide, but also indicated much needs to be done before any change is made.
During a June 29 meeting that showed the battle over race-day furosemide is escalating, supporters ripped their opponents and vowed to take their case -- that the medication is good for the racehorse -- to the public.
Did you miss the live show? Listen now to the archived, on demand, version. Listen Now!
- By Tom LaMarra
Regulators around the country are examining the Kentucky Horse Racing Commission's move to phase out race-day furosemide in graded and listed stakes beginning in 2014, but there doesn't appear to be a rush to follow suit.
The controversial subject of furosemide, the anti-bleeder medication widely used in North American racing, will be the subject of the next "Talkin' Horses with The Blood-Horse" live podcast at 2 p.m. EDT, Tuesday, June 26.
- By Tom LaMarra
The Thoroughbred Racing Associations has endorsed a policy for medication reform that has been supported by many industry stakeholders but so far acted upon piecemeal in various jurisdictions.
Some foreign racing organizations issued statements June 14 backing action by the Kentucky Horse Racing Commission to phase out use of race-day furosemide in graded and listed stakes over three years beginning Jan. 1, 2014.
The Kentucky Horse Racing Commission, by a 7-5 vote with one abstention June 13, approved an administrative regulation that would ban the use of furosemide on race day in graded and listed stakes over a three-year period.
In a development that figures to play out in other racing states, two New York senators said June 12 the anti-bleeding medication furosemide should not be banned on race day.
In advance of an expected vote by the Kentucky Horse Racing Commission June 13, the American Graded Stakes Committee reaffirmed its desire to ban all race-day medication in graded stakes for 2-year-olds.
During an oddly lopsided meeting on a proposal to phase-out use of furosemide on race day in listed and graded stakes in Kentucky, proponents of the therapeutic anti-bleeding medication made their case. But it may not matter.
A new law that allows for an expansion of racetrack card clubs in Minnesota also permits the Minnesota Racing Commission to set threshold testing levels for therapeutic medications used in racehorses.
The Kentucky Horse Racing Commission has scheduled a town hall meeting for June 5 to discuss the proposed three-year phase-out of the race-day drug furosemide.
There doesn't seem to be any middle ground in the debate over the anti-bleeding drug furosemide, and it seems doubtful the two sides will come together any time soon.
The Kentucky Horse Racing Commission May 16 kept alive a proposed regulation to phase out over three years race-day furosemide for graded and listed stakes, but not before the Equine Drug Research Council voted to reject it.
The Jockey Club May 15 released an eight-page letter it submitted to the New York State Racing and Wagering Board the previous day in regard to use of the race-day medication and furosemide and other related issues.
The Thoroughbred Owners and Breeders Association is the latest organization to respond to the New York State Racing and Wagering Board with its opinions on the use of the anti-bleeding medication furosemide on race day.
The Kentucky Horse Racing Commission confirmed it will discuss but not take final action May 16 on a proposal for the three-year phase-out of race-day furosemide in graded and listed stakes.
Most Popular Stories
- California Chrome Works, Set for San Antonio
- Hoppertunity Confirmed for San Antonio Start
- California Chrome Picks Up Cal-Bred Awards
- Callback Rings Up Victory in Las Virgenes
- 'Brandi' Makes Martha Washington Interesting
- The Great War Has More in Store After Romp
- Undefeated Ocean Knight Wins Sam F. Davis
- Early Nominees to Triple Crown Races Increase
- Avanzare Responds For Stevens in Arcadia Win
- Conquest Two Step Surprises in Palos Verdes